Improving influenza vaccines for high-risk populations
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
This study is working on creating better flu vaccines that can protect you longer and are especially helpful for those who need it most, like vulnerable groups, by testing new ideas in both animals and healthy people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11041886 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness and longevity of seasonal influenza vaccines, aiming to develop innovative 'universal influenza vaccines' that provide strong and lasting immunity. The approach involves detailed immunologic assessments of vaccine candidates through pre-clinical animal studies and early-phase clinical trials, including studies with healthy volunteers. The University of Georgia's Center for Influenza Vaccine Research specifically targets vulnerable populations to ensure that the most promising vaccine candidates are advanced into clinical trials. The program leverages a collaborative effort among experienced and emerging researchers, utilizing state-of-the-art facilities and resources.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals from high-risk populations, such as the elderly or those with compromised immune systems.
Not a fit: Patients who are not part of high-risk groups or those who do not receive influenza vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that provide broader and longer-lasting protection, particularly for high-risk groups.
How similar studies have performed: Other research has shown promise in developing universal influenza vaccines, indicating that this approach has potential for success.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Ross, Ted — University of Georgia
- Study coordinator: Ross, Ted
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.